| Withdrawn | The Sequestration of Holistic Stress Management Techniques for Adults NCT06098755 | Goddess Zena I. Jones | N/A |
| Recruiting | Vaccine-induced Immunity in Immunocompromised Patients NCT06612515 | University of Cologne | — |
| Recruiting | Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HS NCT06839456 | Children's Hospital of Philadelphia | Phase 1 / Phase 2 |
| Recruiting | Clozapine-related Immunodeficiency in Parkinsons Disease NCT06634641 | Centre Hospitalier Universitaire, Amiens | Phase 4 |
| Recruiting | SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION NCT06248957 | Karolinska Institutet | — |
| Completed | Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People NCT06576024 | LiuZhou People's Hospital | Phase 4 |
| Active Not Recruiting | Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GA NCT05907746 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled St NCT05587894 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Recruiting | OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients NCT07406217 | Calmy Alexandra | Phase 2 |
| Active Not Recruiting | Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients Wi NCT05405491 | University Hospital, Lille | N/A |
| Recruiting | A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme NCT05027945 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals NCT05655546 | Scripps Translational Science Institute | N/A |
| Withdrawn | Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients NCT05672654 | University Hospital, Ghent | N/A |
| Completed | Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects NCT04408950 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifu NCT04553705 | Beni-Suef University | Phase 2 / Phase 3 |
| Unknown | Immunodeficiency in MS NCT04447937 | Advanced Neurosciences Institute | — |
| Terminated | European Alpha-Mannosidosis Participant NCT03651245 | CENTOGENE GmbH Rostock | — |
| Completed | Immunodeficiency for Severe Epstein-Barr Virus Infection NCT03374566 | Children's Hospital of Fudan University | — |
| Completed | Testing a Novel Dairy Protein to Counteract Immunosenescence NCT03557463 | University of California, Davis | N/A |
| Completed | Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients NCT02651376 | Beijing 302 Hospital | Phase 1 / Phase 2 |
| Terminated | Blood Samples to Identify Biomarkers of Busulfan NCT02291965 | Fred Hutchinson Cancer Center | — |
| Completed | Expanded Access Protocol Thymus Transplantation NCT02274662 | Sumitomo Pharma Switzerland GmbH | Phase 4 |
| Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations NCT01861106 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Susceptibility to Infections in Ataxia Telangiectasia NCT02345135 | Johann Wolfgang Goethe University Hospital | N/A |
| Unknown | Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT01800643 | Hospital Israelita Albert Einstein | Phase 2 / Phase 3 |
| Terminated | Donor Lymphocyte Infusion After Alternative Donor Transplantation NCT01027702 | Wake Forest University Health Sciences | Phase 1 / Phase 2 |
| Completed | Epigenetic Markers of B-Cell Function in Low Birth Weight Infants NCT00925925 | University of Utah | — |
| Completed | Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC NCT00923364 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Trans NCT00758992 | St. Jude Children's Research Hospital | — |
| Recruiting | Genetic Analysis of Immune Disorders NCT00001467 | National Institute of Allergy and Infectious Diseases (NIAID) | — |